Illumina is a global leader in genomics – an industry at the intersection of biology and technology. Our mission is to improve human health by unlocking the power of the genome. Through innovation and collaboration, we are enabling genomic breakthroughs and helping simplify the patient diagnostic odyssey. We dream big. We strive to make solutions increasingly simple, more accessible and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination. https://sapac.illumina.com/areas-of-interest/genetic-disease.html |
ZEISS is a leading international group of companies operating worldwide in the optical andopto-electronic industries. Offering a comprehensive range of microscopy technologiesranging from light, electron, ion and X-ray microscopes, ZEISS is enabling researchers in lifesciences, material science, industrial and clinical applications to achieve new scientificdiscoveries. |
The Royal College of Pathologists of Australasia Quality Assurance Programs are world leaders in the provision of external quality assurance (EQA) for pathology laboratories. We offer a comprehensive range of EQA for all disciplines of pathology including Molecular Genetics, Biosecurity and Point-of-Care. Our programs are offered in Australia and internationally in over 80 countries. RCPAQAP is committed to providing an efficient and customer-focused service to participants. |
The Australasian Society of Diagnostic Genomics Quality Assessment Program is Australasia’s premier provider of proficiency testing and external quality assessments in Clinical Cytogenomics. We provide a comprehensive program for cytogenomic evaluation of blood, prenatal and haematological malignancy samples by G-banded karyotype analysis, Chromosome Microarray Analysis, Fluorescent in situ Hybridisation (FISH) and Formalin-Fixed Paraffin Embedded FISH. The program assesses aspects of the testing process including technical/image quality, result interpretation, and written reports. Laboratory analytical and interpretive competency is evaluated against national regulatory guidelines. The ASDG QAP is an accredited Provider of Proficiency Testing and is compliant with the International Standard ISO/IEC 17043: Conformity assessment – General Requirements for Proficiency Testing |
Conference Secretariat